BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19956889)

  • 21. Lipid-independent effects of an estrogen-statin combination: inhibition of expression of adhesion molecules and plasminogen activator inhibitor--I in human endothelial cell cultures.
    Seeger H; Wallwiener D; Mueck AO
    Climacteric; 2001 Sep; 4(3):209-14. PubMed ID: 11588944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.
    Kelland LR; Mistry P; Abel G; Freidlos F; Loh SY; Roberts JJ; Harrap KR
    Cancer Res; 1992 Apr; 52(7):1710-6. PubMed ID: 1312897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
    Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
    Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926).
    Kilic B; Kruse M; Stahlmann R
    Toxicology; 2006 Jan; 218(1):30-8. PubMed ID: 16297520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of antioxidants and nitric oxide on TNF-alpha-induced adhesion molecule expression and NF-kappaB activation in human dermal microvascular endothelial cells.
    Jiang MZ; Tsukahara H; Ohshima Y; Todoroki Y; Hiraoka M; Maeda M; Mayumi M
    Life Sci; 2004 Jul; 75(10):1159-70. PubMed ID: 15219804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the sensitivity in Chinese hamster cells to photons and fast neutrons by cisplatin, vinblastine, and bleomycin.
    Mokaleng BB; Akudugu JM
    Can J Physiol Pharmacol; 2009 May; 87(5):347-52. PubMed ID: 19448732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of a free radical scavenger, MCI-186, on high-glucose-induced dysfunction of human dermal microvascular endothelial cells.
    Dong J; Takami Y; Tanaka H; Yamaguchi R; Jingping G; Chun Q; Shuliang L; Shimazaki S; Ogo K
    Wound Repair Regen; 2004; 12(6):607-12. PubMed ID: 15555051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
    Louise CB; Obrig TG
    Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
    Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
    Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells.
    De Saint Jean M; Brignole F; Feldmann G; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2199-212. PubMed ID: 10476784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
    Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer.
    Nuver J; Smit AJ; Sleijfer DT; van Gessel AI; van Roon AM; van der Meer J; van den Berg MP; Burgerhof JG; Hoekstra HJ; Sluiter WJ; Gietema JA
    Eur J Cancer; 2004 Mar; 40(5):701-6. PubMed ID: 15010071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
    Hamaguchi E; Takamura T; Shimizu A; Nagai Y
    J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-magnification image analysis of Giemsa stained, electroporation and bleomycin treated endothelial monolayers provides reliable monolayer integrity data.
    Meulenberg CJ; Cemazar M
    Toxicol In Vitro; 2014 Jun; 28(4):502-9. PubMed ID: 24412537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATF3 and PRAP1 play important roles in cisplatin-induced damages in microvascular endothelial cells.
    Li M; Zhai G; Gu X; Sun K
    Gene; 2018 Sep; 672():93-105. PubMed ID: 29886035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of bleomycin A5 on the hemangioma-derived endothelial cell line XTPS-1].
    Li P; Xiao XE; Guo ZT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jun; 47(6):324-8. PubMed ID: 22932480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose responsive effects of cisplatin in L02 cells using NMR-based metabolomics.
    Liu S; Wang W; Zhou X; Gu R; Ding Z
    Environ Toxicol Pharmacol; 2014 Jan; 37(1):150-7. PubMed ID: 24322623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacology of bleomycin and cisplatin.
    Evans WE; Yee GC; Crom WR; Pratt CB; Green AA
    Head Neck Surg; 1981; 4(2):98-110. PubMed ID: 6171547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.